Financial Instruments And Risk Management (Tables)

3 Months Ended

Mar. 31, 2013

Financial Assets And Liabilities Carried At Fair Value

Financial assets and liabilities carried at fair value are classified in the tables below in one of the three categories described above:



	March 31, 2013
(In thousands)	Level 1		Level 2		Level 3		Total
Financial Assets
Cash equivalents:
Money market funds	$	62,194	$	—	$	—	$	62,194
Total cash equivalents	62,194		—		—		62,194
Trading securities:
Equity securities — exchange traded funds	11,715		—		—		11,715
Total trading securities	11,715		—		—		11,715
Available-for-sale fixed income investments:
U.S. Treasuries	—		11,148		—		11,148
Corporate bonds	—		7,889		—		7,889
Agency mortgage-backed securities	—		937		—		937
Other	—		2,476		—		2,476
Total available-for-sale fixed income investments	—		22,450		—		22,450
Available-for-sale equity securities:
Biosciences industry	83		—		—		83
Total available-for-sale equity securities	83		—		—		83
Foreign exchange derivative assets	—		7,093		—		7,093
Interest rate swap derivative assets	—		35,026		—		35,026
Purchased cash convertible note hedge	—		691,600		—		691,600
Total assets at fair value	$	73,992	$	756,169	$	—	$	830,161
Financial Liabilities
Foreign exchange derivative liabilities	$	—	$	5,903	$	—	$	5,903
Interest rate swap derivative liabilities	—		8,203		—		8,203
Cash conversion feature of Cash Convertible Notes	—		691,600		—		691,600
Contingent consideration	—		—		385,021		385,021
Total liabilities at fair value	$	—	$	705,706	$	385,021	$	1,090,727



	December 31, 2012
(In thousands)	Level 1		Level 2		Level 3		Total
Financial Assets
Cash equivalents:
Money market funds	$	135,209	$	—	$	—	$	135,209
Total cash equivalents	135,209		—		—		135,209
Trading securities:
Equity securities — exchange traded funds	10,913		—		—		10,913
Total trading securities	10,913		—		—		10,913
Available-for-sale fixed income investments:
U.S. Treasuries	—		11,085		—		11,085
Corporate bonds	—		8,189		—		8,189
Agency mortgage-backed securities	—		1,050		—		1,050
Other	—		2,502		—		2,502
Total available-for-sale fixed income investments	—		22,826		—		22,826
Available-for-sale equity securities:
Biosciences industry	102		—		—		102
Total available-for-sale equity securities	102		—		—		102
Foreign exchange derivative assets	—		5,818		—		5,818
Interest rate swap derivative assets	—		36,647		—		36,647
Purchased cash convertible note hedge	—		636,300		—		636,300
Total assets at fair value	$	146,224	$	701,591	$	—	$	847,815
Financial Liabilities
Foreign exchange derivative liabilities	$	—	$	19,228	$	—	$	19,228
Interest rate swap derivative liabilities	—		9,823		—		9,823
Cash conversion feature of Cash Convertible Notes	—		636,300		—		636,300
Contingent consideration	—		—		379,197		379,197
Total liabilities at fair value	$	—	$	665,351	$	379,197	$	1,044,548

Designated as Hedging Instrument

Derivative [Line Items]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Fair Values of Derivative Instruments

Derivatives Designated as Hedging Instruments



	Asset Derivatives
	March 31, 2013			December 31, 2012
(In thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest rate swaps	Prepaid expenses and other current assets	$	35,026	Prepaid expenses and other current assets	$	36,647
Foreign currency forward contracts	Prepaid expenses and other current assets	3,900		Prepaid expenses and other current assets	—
Total		$	38,926		$	36,647



	Liability Derivatives
	March 31, 2013			December 31, 2012
(In thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest rate swaps	Other current liabilities	$	8,203	Other current liabilities	$	9,823
Foreign currency forward contracts	Other current liabilities	—		Other current liabilities	15,863
Total		$	8,203		$	25,686

Not Designated as Hedging Instruments

Derivative [Line Items]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

Fair Values of Derivative Instruments

Derivatives Not Designated as Hedging Instruments



	Asset Derivatives
	March 31, 2013			December 31, 2012
(In thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign currency forward contracts	Prepaid expenses and other current assets	$	3,193	Prepaid expenses and other current assets	$	5,818
Purchased cash convertible note hedge	Other assets	691,600		Other assets	636,300
Total		$	694,793		$	642,118



	Liability Derivatives
	March 31, 2013			December 31, 2012
(In thousands)	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Foreign currency forward contracts	Other current liabilities	$	5,903	Other current liabilities	$	3,365
Cash conversion feature of Cash Convertible Notes	Long-term debt	691,600		Long-term debt	636,300
Total		$	697,503		$	639,665

Effect Of Derivative Instruments On The Condensed Consolidated Statements Of Operations

The Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations

Derivatives Not Designated as Hedging Instruments



	Location of Gain or (Loss) Recognized in Earnings on Derivatives	Amount of Gain or (Loss) Recognized in Earnings on Derivatives
		Three Months Ended
		March 31,
(In thousands)		2013			2012
Foreign currency forward contracts	Other income (expense), net	$	(11,231	)	$	5,255
Cash conversion feature of Cash Convertible Notes	Other income (expense), net	(55,300		)	(51,600		)
Purchased cash convertible note hedge	Other income (expense), net	55,300			51,600
Total		$	(11,231	)	$	5,255

Fair Value Hedging Relationships

Derivative [Line Items]

Effect Of Derivative Instruments On The Condensed Consolidated Statements Of Operations

The Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations

Derivatives in Fair Value Hedging Relationships



	Location of Gain or (Loss) Recognized in Earnings on Derivatives	Amount of Gain or (Loss) Recognized in Earnings on Derivatives
(In thousands)		Three Months Ended
		March 31,
		2013			2012
Interest rate swaps	Interest expense	$	(1,800	)	$	11,896
Total		$	(1,800	)	$	11,896



	Location of Gain or(Loss) Recognized in Earnings on Hedged Items	Amount of Gain or (Loss) Recognized in Earnings on Hedging Items
(In thousands)		Three Months Ended
		March 31,
		2013		2012
2018 Senior Notes	Interest expense	$	5,309	$	(8,825	)
Total		$	5,309	$	(8,825	)

Cash Flow Hedging Relationships

Derivative [Line Items]

Effect Of Derivative Instruments On The Condensed Consolidated Statements Of Operations

The Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations

Derivatives in Cash Flow Hedging Relationships



	Amount of Gain or (Loss) Recognized in AOCE (Net of Tax) on Derivative (Effective Portion)
	Three Months Ended
	March 31,
(In thousands)	2013		2012
Foreign currency forward contracts	$	4,737	$	11,461
Interest rate swaps	4,708		(1,324		)
Total	$	9,445	$	10,137



	Location of Loss Reclassified from AOCE into Earnings (Effective Portion)	Amount of Loss Reclassified from AOCE into Earnings (Effective Portion)
		Three Months Ended
		March 31,
(In thousands)		2013			2012
Foreign currency forward contracts	Net revenues	$	(9,104	)	$	(5,255	)
Interest rate swaps	Interest expense	(712		)	(374		)
Total		$	(9,816	)	$	(5,629	)



	Location of Gain Excluded from the Assessment of Hedge Effectiveness	Amount of Gain Excluded from the Assessment of Hedge Effectiveness
		Three Months Ended
		March 31,
(In thousands)		2013		2012
Foreign currency forward contracts	Other income (expense), net	$	8,108	$	5,711
Total		$	8,108	$	5,711

- Definition

Tabular disclosure of the location and amount of gains and losses reported in the statement of financial performance, or when applicable, the statement of financial position. For example, (a) gains and losses recognized in the income statement on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges and (b) gains and losses initially recognized in other comprehensive income on derivative instruments designated and qualifying as cash flow hedges.

+ References+ Details

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References+ Details